Company intelligence / Profile preview

Ikänik Farms

Corona, California, United States

Ownership: Private
Development stage: Other

Overview

Ikänik Farms, through its Colombian pharma division Pideka, produces GACP- and GMP-Pharma-certified cannabis oils and other products for medical and pharmaceutical applications. It supported an in vitro research program with CAS Biotechnology in Mexico to test effects of cannabinoids on SARS-CoV-2 viral proteins, but there is no evidence of clinical trials or approved drugs.[1][2][3][6]

Therapeutic areas: NeurologyPsychiatryInfectious DiseasesGastroenterologyOncology
Modalities: Plant-derived extractPhytotherapeuticSmall molecule
Industry: Biotech

Partnerships

CAS Biotechnology (Mexico) – collaborative agreement to research potential medical benefits of pharmaceutical-grade cannabis oil for COVID-19, including in vitro studies on SARS-CoV-2 replication and interaction with viral proteins and human receptors.[1][2][3][6]

Beyond the preview

Go deeper on Ikänik Farms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ikänik Farms.

Explore the full profile